Literature DB >> 2361821

HLA antigens and multiple sclerosis in Northern Ireland.

S A Hawkins1, C Cullen, D Middleton, J I Morrow.   

Abstract

Multiple sclerosis has been shown to be associated with the presence of certain major histocompatibility (MHC) tissue antigens which are coded on chromosome 6. There are racial differences in the antigens associated with MS. The strength of the associations vary in different communities in Western Europe. We have investigated the association between MS and MCH antigens in Northern Ireland in a group of 104 patients. There is a particularly strong association between MS and HLA-DR2, 65.4% compared with 25.5% in 184 controls. A weaker association has been demonstrated with HLA-A3 (44.2% vs 26.5% in controls). There have been conflicting reports concerning an association of HLA-DW2 and HLA-DR2 with a rapidly progressive form of MS. Our data do not support that hypothesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2361821     DOI: 10.1007/bf02946670

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  12 in total

1.  Frequency and associations of HLA class II TaqI allogenotypes in the Northern Ireland population.

Authors:  C G Cullen; D Middleton; D A Savage
Journal:  Hum Immunol       Date:  1990-10       Impact factor: 2.850

2.  The distribution of multiple sclerosis in the United Kingdom.

Authors:  R J Swingler; D Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-10       Impact factor: 10.154

3.  A double-blind trial of transfer factor vs placebo in multiple sclerosis patients.

Authors:  R C Collins; L R Espinoza; C R Plank; G C Ebers; R A Rosenberg; J B Zabriskie
Journal:  Clin Exp Immunol       Date:  1978-07       Impact factor: 4.330

4.  The HLA-DR antigen frequency in Northern Ireland compared to the frequency in Bristol, Edinburgh and Eire.

Authors:  D Middleton; J Jordan; J Martin; S Spencer
Journal:  Tissue Antigens       Date:  1985-04

5.  Histocompatibility determinants in multiple sclerosis, with special reference to clinical course.

Authors:  C Jersild; T Fog; G S Hansen; M Thomsen; A Svejgaard; B Dupont
Journal:  Lancet       Date:  1973-12-01       Impact factor: 79.321

Review 6.  Diagnosis and classification of multiple sclerosis.

Authors:  W I McDonald; A M Halliday
Journal:  Br Med Bull       Date:  1977-01       Impact factor: 4.291

7.  Different B lymphocyte alloantigens associated with multiple sclerosis in Arabs and North Europeans.

Authors:  A Kurdi; I Ayesh; A Abdallat; U Maayta
Journal:  Lancet       Date:  1977-05-28       Impact factor: 79.321

8.  Genetic basis of multiple sclerosis: HLA antigens, disease progression, and oligoclonal IgG in CSF.

Authors:  L Stendahl-Brodin; H Link; E Möller; E Norrby
Journal:  Acta Neurol Scand       Date:  1979-06       Impact factor: 3.209

9.  Multiple sclerosis in north-east Scotland. An association with HLA-DQw1.

Authors:  D A Francis; J R Batchelor; W I McDonald; S N Hing; I A Dodi; A H Fielder; J E Hern; A W Downie
Journal:  Brain       Date:  1987-02       Impact factor: 13.501

10.  HLA antigen frequency of Northern Ireland blood donors.

Authors:  D Middleton; J Martin
Journal:  Ulster Med J       Date:  1978
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.